Editas Medicine Inc (0IFK)

London
Currency in USD
2.92
-0.14(-4.57%)
Closed·
0IFK Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
0IFK is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.803.07
52 wk Range
0.925.97
Key Statistics
Edit
Prev. Close
-
Open
2.92
Day's Range
2.8-3.07
52 wk Range
0.92-5.97
Volume
29.08K
Average Vol. (3m)
42.09K
1-Year Change
-46.03%
Book Value / Share
0.75
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
0IFK Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
4 analysts have revised their earnings upwards for the upcoming period

Editas Medicine Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Editas Medicine Inc Company Profile

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene editing platform based on CRISPR technology. It has a research collaboration with Juno Therapeutics, Inc. to develop alpha-beta T-cell experimental medicines for the treatment of solid and liquid tumors. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.

Compare 0IFK to Peers and Sector

Metrics to compare
0IFK
Peers
Sector
Relationship
P/E Ratio
−1.0x−1.5x−0.5x
PEG Ratio
0.02−0.070.00
Price / Book
3.9x1.5x2.6x
Price / LTM Sales
6.7x12.5x3.1x
Upside (Analyst Target)
-250.7%46.1%
Fair Value Upside
Unlock22.9%6.9%Unlock

Earnings

Latest Release
May 12, 2025
EPS / Forecast
-0.92 / -0.5571
Revenue / Forecast
4.66M / 786.10K
EPS Revisions
Last 90 days

0IFK Income Statement

People Also Watch

125.84
CRWV
-9.00%
44.73
BILL
-3.58%
6.440
BBAI
-9.55%
104.43
CRUS
-1.79%

FAQ

What Is the Editas Medicine Inc (0IFK) Stock Price Today?

The Editas Medicine Inc stock price today is 2.92

What Stock Exchange Does Editas Medicine Inc Trade On?

Editas Medicine Inc is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Editas Medicine Inc?

The stock symbol for Editas Medicine Inc is "0IFK."

What Is the Editas Medicine Inc Market Cap?

As of today, Editas Medicine Inc market cap is 241.09M.

What Is Editas Medicine Inc's Earnings Per Share (TTM)?

The Editas Medicine Inc EPS (TTM) is -3.04.

When Is the Next Editas Medicine Inc Earnings Date?

Editas Medicine Inc will release its next earnings report on Jul 30, 2025.

From a Technical Analysis Perspective, Is 0IFK a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Editas Medicine Inc Stock Split?

Editas Medicine Inc has split 0 times.

How Many Employees Does Editas Medicine Inc Have?

Editas Medicine Inc has 246 employees.

What is the current trading status of Editas Medicine Inc (0IFK)?

As of Jul 12, 2025, Editas Medicine Inc (0IFK) is trading at a price of 2.92, with a previous close of 0.00. The stock has fluctuated within a day range of 2.80 to 3.07, while its 52-week range spans from 0.92 to 5.97.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.